
Bruno Villoutreix, PhD
INSERM U648
Université Paris Diderot - Paris7
35 rue Hélène Brion - 75013 Paris
With Dr. Bruno Villoutreix we have established a longterm collaboration, and he has truely been, and still is, an inspiration to our laboratory. He has extensive experience in various aspects of structural bioinformatics, in particular those of blood coagulation proteins. Although at present he has broadened his focus to other research fields, we still collaborate in particular with respect to virtual ligand screening techniques. Other members of his team, Maria Miteva and Olivier Sperandio, are also involved in these collaborative efforts.
Björn Dahlbäck, MD, PhD
Professor of Blood Coagulation Research
Department of Laboratory Medicine, division of Clinical Chemistry
Lund University
University Hospital, Malmö
Malmö, Sweden
With Prof. Björn Dahlbäck we have a collaboration on the structure function studies of coagulation factor V and its regulation by the protein C system. Prof. Dahlbäck is an authority with respect to factor V and is the discoverer of APC resistance. Besides his interest in coagulation and the complement system he has widened his scientific horizon ever since he discovered apolipoprotein M, a protein important to the lipoprotein physiology and the etiology of atherosclerotic disease.
Svetla Stoilova-McPhie, PhD
Division of Structural Biology, OPIC
Wellcome Trust Centre for Human Genetics
University of Oxford, Roosevelt Drive
Oxford OX3 7BN, UK
With Dr. Stoylova we have had a collaboration since 1999, in a structural genomics study in which we aim at gaining a better and more detailed insight into the 3D structure of coagulation factor V and its ligands. Dr. Stoylova is an expert in the EM based methods for solving (macromolecular) structures.
Cathy Hayward, MD, PhD
Department of Pathology and Molecular Medicine/Medicine
McMaster University
Hamilton, Ontario Canada
With Dr. Hayward we collaborate in the research of multimerin, a platelet protein discovered by Dr. Hayward and which has been shown to be a binding partner of coagulation factor V.
Jan Voorberg, PhD
Department of Plasma Proteins
Sanquin Research
Plesmanlaan 125
1066 CX Amsterdam
With Dr. Voorberg we are currently performing pilot studies in the field of coagulation factor VIII research.
Paul E. Bock, Ph.D.
Department of Pathology
Vanderbilt University School of Medicine
Nashville, Tennessee, United States
Prof. Bock has visited the maastricht laboratory as a visiting professor during a sabbatical leave and has boosted the interest we have in using fluorescence techniques for quantitative measurements in the structure-function studies of coagulation factors as well as snake venoms. With respect to these common research interests we have started collaborations.
Chris Reutelingsperger
Department of Biochemistry
Maastricht University
Dr. Reutelingsperger, who heads a research group within the Biochemistry department is the discoverer of Annexin V, the protein that can bind specifically to phospolipid membranes that contain the net negatively phosphatidylserine. We are currently involved in a structure function study that tries to indentify key residues in the Annexin V molecule that are essential for its biological functions. Our unit supplies the bioinformatics input that forms the basis of these ongoing studies.
Ludovic Autin
Equipe de Bioinformatique Genomique et Moleculaire
INSERM U726, Universite Paris 7
Paris, FRANCE
Ludovic has visited the Maastricht lab, as a PhDstudent of the Villoutreix lab. Since then we collaborate mainly on the topic of the macromolecular organisations of coagulation proteins.
Esther Lutgens
Pathology Department
Academic Hospital Maastricht
Maastricht, the Netherlands
Together with Esther we are involved in the discovery and optimization of small molecules that may be used in the treatment of patients suffering from atherosclerosis.
Kees van 't Veer
Center for Experimental and Molecular Medicine and the Center for Infection and Immunity Amsterdam
AMC, Amsterdam, the Netherlands
With Kees we have an ongoing collaboration in the modelling and targetting of proteins involved in the immune system. So far several models have been produced, based on which, mutagenesis studies were performed that verified the correctness of our models.
Kenneth Segers
K.U.Leuven. Rega Institute for Medical Research Dept. Microbiology and Immunology, Div. Bacteriology
Leuven, Belgium
Kenneth, former member of our group and a good friend of ours is working in the field of antibiotics and antibiotics resistance. Together we have embarked upon a project to identify and optimize new molecules that can target bacteria, using a novel approach.
Jean Luc Pellequer
The group of Jean Luc and ours share an interest in blood coagulation protein structure. Using atomic force microscopy jean Luc is able to do fascinating things. We share materials and ideas in order to gain information on selected proteins.